Join
Live feed
·
INSIDERFilingvia Quantisnow
BiomX Inc. logo

Amendment: Chief Development Officer Bassan Merav was granted 79,597 shares (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
PHGE· BiomX Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track PHGE (BiomX Inc.) and more on Quantisnow.